关注
Francesca Cancelli
Francesca Cancelli
未知所在单位机构
在 uniroma1.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature
A Oliva, G Siccardi, A Migliarini, F Cancelli, M Carnevalini, M D’Andria, ...
Infection 48, 871-877, 2020
642020
Low-grade endotoxemia and thrombosis in COVID-19
A Oliva, V Cammisotto, R Cangemi, D Ferro, MC Miele, M De Angelis, ...
Clinical and translational gastroenterology 12 (6), e00348, 2021
482021
Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection
FC Dezza, A Oliva, F Cancelli, G Savelloni, S Valeri, V Mauro, ...
Diagnostic microbiology and infectious disease 100 (2), 115347, 2021
462021
In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem …
A Oliva, L Scorzolini, A Cipolla, MT Mascellino, F Cancelli, D Castaldi, ...
Journal of Antimicrobial Chemotherapy 72 (7), 1981-1984, 2017
442017
Efficacy of two micro-gravitational protocols to treat chronic low back pain associated with discal lesions: a randomized controlled trial
R Saggini, F Cancelli, V Di Bonaventura, RG Bellomo
European Journal of Physical and Rehabilitation Medicine 40 (4), 311, 2004
342004
Role of Double‐Carbapenem Regimen in the Treatment of Infections due to Carbapenemase Producing Carbapenem‐Resistant Enterobacteriaceae: A Single …
F Cancelli, A Oliva, M De Angelis, MT Mascellino, CM Mastroianni, ...
BioMed Research International 2018 (1), 2785696, 2018
272018
Role of serum E-selectin as a biomarker of infection severity in coronavirus disease 2019
A Oliva, E Rando, D Al Ismail, M De Angelis, F Cancelli, MC Miele, ...
Journal of Clinical Medicine 10 (17), 4018, 2021
212021
Effect of N-acetylcysteine administration on 30-day mortality in critically ill patients with septic shock caused by carbapenem-resistant Klebsiella pneumoniae and …
A Oliva, A Bianchi, A Russo, G Ceccarelli, F Cancelli, F Aloj, ...
Antibiotics 10 (3), 271, 2021
212021
Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and …
A Oliva, F Cancelli, A Brogi, A Curtolo, G Savelloni, G Siccardi, G Marcelli, ...
New Microbiologica 45 (1), 62-72, 2022
132022
Prognostic Value of 12-Leads Electrocardiogram at Emergency Department in Hospitalized Patients with Coronavirus Disease-19
G Savelloni, MC Gatto, F Cancelli, A Barbetti, F Cogliati Dezza, C Franchi, ...
Journal of Clinical Medicine 11 (9), 2537, 2022
112022
Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non …
A Oliva, A Curtolo, L Volpicelli, F Cancelli, C Borrazzo, F Cogliati Dezza, ...
Infection 50 (5), 1373-1382, 2022
10*2022
Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: analysis of cases and evaluation of in vitro activity of fosfomycin-containing …
A Oliva, D Al Ismail, G Arcari, MC Miele, E Casali, F Sacco, L Volpicelli, ...
Journal of Global Antimicrobial Resistance 33, 321-327, 2023
92023
Real-life use of remdesivir-containing regimens in COVID-19: a retrospective case-control study
FC Dezza, A Oliva, V Mauro, FE Romani, R Aronica, G Savelloni, E Casali, ...
Le Infezioni in Medicina 30 (2), 211, 2022
92022
Composition of the essential oil of Coristospermum cuneifolium and antimicrobial activity evaluation
A Venditti, C Frezza, G Salutari, M di Cecco, G Ciaschetti, A Oliva, ...
Planta Medica International Open 4 (02), e74-e81, 2017
82017
CURB-65 plus hypoalbuminemia: a new score system for prediction of the in-hospital mortality risk in patients with SARS-CoV-2 pneumonia
A Oliva, C Borrazzo, MT Mascellino, A Curtolo, D Al Ismail, F Cancelli, ...
Le Infezioni in Medicina 29 (3), 408, 2021
52021
Association between PaO2/FiO2 ratio and thrombotic events in COVID-19 patients
L Loffredo, P Pignatelli, M Pirro, G Ceccarelli, A Oliva, E Maggio, ...
Internal and Emergency Medicine 18 (3), 889-895, 2023
42023
Clinical characteristics and risk factors for mortality in COVID-19 patients during the first wave of the COVID-19 pandemic in Rome, Italy: a single-center retrospective study
E Rando, A Oliva, F Cancelli, C D’Agostino, G Savelloni, MR Ciardi, ...
Le Infezioni in Medicina 31 (1), 49, 2023
42023
Real-life experience in the use of ceftobiprole for the treatment of nosocomial pneumonia: a case series
A Oliva, G Savellon, F Cancelli, S Valeri, V Mauro, R Aronica, F Romani, ...
Journal of Global Antimicrobial Resistance 26, 52-54, 2021
42021
Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies: results from the HM-COV 2.0 study
A Oliva, F Cogliati Dezza, F Petrucci, FE Romani, M Morviducci, ...
Clinical and Experimental Medicine 23 (6), 2275-2285, 2023
32023
Real-world use of imipenem/cilastatin/relebactam for the treatment of KPC-producing Klebsiella pneumoniae complex and difficult-to-treat resistance (DTR) Pseudomonas aeruginosa …
C Leanza, MT Mascellino, L Volpicelli, S Covino, A Falletta, F Cancelli, ...
Frontiers in Microbiology 15, 1432296, 2024
12024
系统目前无法执行此操作,请稍后再试。
文章 1–20